John Paul Bouffard, MD | |
1 Diamond Hill Rd Fl G, Berkeley Heights, NJ 07922-2104 | |
(908) 277-8699 | |
(908) 673-7388 |
Full Name | John Paul Bouffard |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 34 Years |
Location | 1 Diamond Hill Rd Fl G, Berkeley Heights, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306801931 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZN0500X | Pathology - Neuropathology | 25MA08115900 (New Jersey) | Secondary |
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 25MA08115900 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Overlook Medical Center | Summit, NJ | Hospital |
Morristown Medical Center | Morristown, NJ | Hospital |
Chilton Medical Center | Pompton plains, NJ | Hospital |
Newton Medical Center | Newton, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Morristown Pathology Associates Pa | 4981699717 | 29 |
News Archive
The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.
A new survey has found that a significant number of young men have used erectile dysfunction, (ED), medications such as Viagra often in conjunction with other recreational drugs, and most without consulting a physician.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.
Using an experimental co-culture approach in which two different types of neurons from a mouse model of Huntington's disease (HD) are grown side-by-side, connecting to form critically impacted circuits, researchers at University of California San Diego School of Medicine have identified a subunit of a protein that, when expressed, reverse the mutated gene effects responsible for HD.
Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced the launch of AVIGA and AVIGA REPORTER. AVIGA is a web-based electronic health record (EHR) solution with HIV/AIDS disease-specific functionality and AVIGA REPORTER is a web-based, data-reporting module designed specifically for the purposes of conducting HIV/AIDS research and providing reporting capabilities.
› Verified 2 days ago
Entity Name | Summit Medical Group Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942254347 PECOS PAC ID: 5395642276 Enrollment ID: O20031218000011 |
News Archive
The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.
A new survey has found that a significant number of young men have used erectile dysfunction, (ED), medications such as Viagra often in conjunction with other recreational drugs, and most without consulting a physician.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.
Using an experimental co-culture approach in which two different types of neurons from a mouse model of Huntington's disease (HD) are grown side-by-side, connecting to form critically impacted circuits, researchers at University of California San Diego School of Medicine have identified a subunit of a protein that, when expressed, reverse the mutated gene effects responsible for HD.
Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced the launch of AVIGA and AVIGA REPORTER. AVIGA is a web-based electronic health record (EHR) solution with HIV/AIDS disease-specific functionality and AVIGA REPORTER is a web-based, data-reporting module designed specifically for the purposes of conducting HIV/AIDS research and providing reporting capabilities.
› Verified 2 days ago
Entity Name | Morristown Pathology Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922075886 PECOS PAC ID: 4981699717 Enrollment ID: O20040420000045 |
News Archive
The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.
A new survey has found that a significant number of young men have used erectile dysfunction, (ED), medications such as Viagra often in conjunction with other recreational drugs, and most without consulting a physician.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.
Using an experimental co-culture approach in which two different types of neurons from a mouse model of Huntington's disease (HD) are grown side-by-side, connecting to form critically impacted circuits, researchers at University of California San Diego School of Medicine have identified a subunit of a protein that, when expressed, reverse the mutated gene effects responsible for HD.
Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced the launch of AVIGA and AVIGA REPORTER. AVIGA is a web-based electronic health record (EHR) solution with HIV/AIDS disease-specific functionality and AVIGA REPORTER is a web-based, data-reporting module designed specifically for the purposes of conducting HIV/AIDS research and providing reporting capabilities.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
John Paul Bouffard, MD 1 Diamond Hill Rd, Berkeley Heights, NJ 07922-2104 Ph: () - | John Paul Bouffard, MD 1 Diamond Hill Rd Fl G, Berkeley Heights, NJ 07922-2104 Ph: (908) 277-8699 |
News Archive
The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.
A new survey has found that a significant number of young men have used erectile dysfunction, (ED), medications such as Viagra often in conjunction with other recreational drugs, and most without consulting a physician.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.
Using an experimental co-culture approach in which two different types of neurons from a mouse model of Huntington's disease (HD) are grown side-by-side, connecting to form critically impacted circuits, researchers at University of California San Diego School of Medicine have identified a subunit of a protein that, when expressed, reverse the mutated gene effects responsible for HD.
Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced the launch of AVIGA and AVIGA REPORTER. AVIGA is a web-based electronic health record (EHR) solution with HIV/AIDS disease-specific functionality and AVIGA REPORTER is a web-based, data-reporting module designed specifically for the purposes of conducting HIV/AIDS research and providing reporting capabilities.
› Verified 2 days ago
Nikolay D Dimov, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-277-8699 Fax: 908-673-7388 | |
Mr. Ara Meradian, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-277-8699 Fax: 908-673-7388 | |
Gabriel S Levi, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd Fl G, Berkeley Heights, NJ 07922 Phone: 908-277-8699 Fax: 908-673-7388 | |
Anup Hazra, Pathology Medicare: Medicare Enrolled Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300 Fax: 908-277-8756 | |
Fang Qian, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300 | |
Rachel C Ochs, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300 |